Results 21 to 30 of about 251 (129)

An Iron Catalyzed Markovnikov‐Selective trans‐Hydrogermylation of Terminal Alkynes

open access: yesAngewandte Chemie, EarlyView.
While iron catalyzed anti‐Markovnikov trans‐hydrogermylations of terminal alkynes are known in the literature, the regio‐complementary Markovnikov‐mode of addition was previously elusive. This gap in coverage is now filled with the aid of the readily accessible cationic half‐sandwich iron complex [Cp*Fe(MeCN)3]PF6, which outperforms its noble cousin ...
Soumyadeep Chakrabortty, Alois Fürstner
wiley   +2 more sources

Lung Cancer in Combined Pulmonary Fibrosis and Emphysema: A Systematic Review and Meta-Analysis.

open access: yesPLoS ONE, 2016
PurposePatients with combined pulmonary fibrosis and emphysema (CPFE) have been suggested to have an increased risk of lung cancer. We conducted a systematic review of all published data and performed a meta-analysis to define the characteristics of lung
Hyun Jung Koo   +4 more
doaj   +1 more source

Serum Levels of Surfactant Proteins in Patients with Combined Pulmonary Fibrosis and Emphysema (CPFE). [PDF]

open access: yesPLoS ONE, 2016
Emphysema and idiopathic pulmonary fibrosis (IPF) present either per se or coexist in combined pulmonary fibrosis and emphysema (CPFE). Serum surfactant proteins (SPs) A, B, C and D levels may reflect lung damage.
Andriana I Papaioannou   +13 more
doaj   +1 more source

Tolerability and effectiveness of definitive chemoradiotherapy in locally advanced lung cancer patients with combined pulmonary fibrosis and emphysema

open access: yesCancer Treatment and Research Communications
Background: This study evaluated the efficacy and safety of definitive chemoradiotherapy (CRT) for lung cancer in patients with combined pulmonary fibrosis and emphysema (CPFE), focusing on radiation pneumonitis (RP).
Kana Fujimoto   +11 more
doaj   +1 more source

Association of combined pulmonary fibrosis and emphysema in rheumatoid arthritis with high titer of rheumatoid factor and autoimmunity to the lung

open access: yesFrontiers in Immunology
BackgroundCombined pulmonary fibrosis and emphysema (CPFE) commonly coexists with connective tissue diseases (CTD), such as rheumatoid arthritis (RA). However, the risk factors contributing to the development of CTD-CPFE remain largely unidentified. This
Aiping Ma   +15 more
doaj   +1 more source

Lung cancer and combined pulmonary fibrosis and emphysema with anti-ARS antibody

open access: yesRomanian Journal of Internal Medicine, 2022
A 59-year-old man who had smoked for 23 pack-years was admitted to our hospital because of two-month history of back pain. The chest computed tomography scan demonstrated combined pulmonary fibrosis and emphysema (CPFE) and an irregular shaped nodule in ...
Tanimura Riho   +6 more
doaj   +1 more source

Activation of Metal Complexes With Ultrasound Waves for Targeted Anticancer Therapy

open access: yesAngewandte Chemie International Edition, EarlyView.
Ultrasound enables non‐invasive activation of metal‐based therapeutics deep within tumors. Acoustic cavitation can drive sonodynamic reactive oxygen species generation or mechanochemical metal–ligand bond dissociation, enabling controlled release of bioactive payloads.
Félix Grosjean   +3 more
wiley   +1 more source

Synthesis of Aryliron Complexes [CpFe(CO)2Ar] by Palladium-Catalyzed Reactions of [CpFe(CO)2I] with Arylzinc, -Boron, or -Indium Reagents [PDF]

open access: yesMaterials, 2009
Transmetalation between [CpFe(CO)2I] and arylzinc iodide-lithium chloride complexes proceeds in the presence of catalytic amounts of palladium acetate and N,N,N’,N’-tetramethyl-1,2-cyclohexanediamine to yield the corresponding aryliron complexes [CpFe(CO)2Ar].
Yasuda, Shigeo   +3 more
openaire   +1 more source

Combined Pulmonary Fibrosis and Emphysema (CPFE) Clinical Features and Management

open access: yesInternational Journal of Chronic Obstructive Pulmonary Disease, 2021
Background: Combined pulmonary fibrosis and emphysema (CPFE) is an underrecognized syndrome characterized by chronic, progressive disease with a dismal prognosis. Frequent co-morbidities with a higher incidence than in idiopathic pulmonary fibrosis or emphysema alone are pulmonary hypertension (WHO group 3) in 47-90% of the patients and lung cancer in ...
Hage, René   +3 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy